Adial pharmaceuticals to present at 23rd annual icr conference

Charlottesville, va / accesswire / january 11, 2021 / adial pharmaceuticals, inc. (nasdaq:adil; adilw) ("adial" or the "company"), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that william stilley, chief executive officer of adial pharmaceuticals has been invited to present a company overview at the 23rd annual icr conference on thursday, january 14, 2021 at 3:15pm-3:55pm eastern time. a live webcast of the company's presentation will be available on the investors section of the company's website (https://www.adialpharma.com/).
ADIL Ratings Summary
ADIL Quant Ranking